N.M., June 30, 2020 (GLOBE NEWSWIRE) -PRESS RELEASE- New Mexico’s Medical
Cannabis Program will officially begin allowing out-of-state medical cannabis
patients to possess and purchase medical cannabis while in New Mexico. Ultra Health, a New Mexico cannabis company, will be providing medical cannabis for
reciprocal participants on July 1, 2020.
proof of authorization from a medical cannabis program outside New Mexico, also
known as reciprocal participants, may begin purchasing medical cannabis from
New Mexico dispensaries on July 1, 2020, without paying any additional fee.
Reciprocal participants may purchase and possess up to 230 units or 8 ounces of
cannabis in a 90-day period.
reciprocity legislation is among the most lenient in the country, allowing
medical cannabis patients with proof of authorization from any state, the
District of Columbia, a territory or commonwealth of the U.S. or a New Mexico
Indian nation, tribe or pueblo to purchase medical cannabis while in New
other reciprocal programs in medical cannabis states require a medical cannabis
“card” specifically, New Mexico’s program only requires proof of authorization
which includes doctor recommendations like those more commonly issued in
California. Additionally, reciprocal participants may have qualifying
conditions that are not currently approved for medical cannabis patient status
in New Mexico, and they are not required to comply with New Mexico’s patient
card application nor renewal requirements.
with an authorization for medical cannabis from outside of New Mexico will have
an easier qualification than a New Mexican cardholder in regard to multi-state
eligibility, purchase limits and cost to participate.
was passed during the 2019 Legislative Session when lawmakers made sweeping
changes to the Lynn and Erin Compassionate Use Act for the first time
since the bill was originally passed in 2007.
exciting to see New Mexico’s Medical Cannabis Program begin to embrace
continuity of care,” said Duke Rodriguez, CEO and president of Ultra Health.
“Access to healthcare, especially medical cannabis, should not be limited to
arbitrary requirements like where a person lives or whether the state believes
their condition should qualify. The ongoing challenge now will be to provide
for the medical cannabis needs of 100,000 New Mexicans and the added reciprocal
visitors from out-of-state amid historic medical cannabis supply shortages and
is the largest vertically integrated medical cannabis provider in the United
States. The provider currently operates 20 dispensary locations statewide, with
another 10 stores slated to open by the third quarter of 2020. Ultra Health
provides unparalleled medical cannabis care by producing accurately dosed, smokeless
cannabis products such as sublingual tablets, oils, pastilles, suppositories
and more through its partnership with Israel-based pharmaceutical group
Panaxia. Ultra Health sees itself as being at the forefront of patient-rights
issues and says it will continue to fight for adequate supply and rural access
in the New Mexico medical cannabis market.